Clinical Trial

Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2024 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
In a transvaginal tru-cut biopsy, guided by ultrasound, a needle is inserted through the vaginal wall into a pelvic lesion and a few pieces of tissue are obtained for examination. This clinical trial is organized to evaluate the safety and efficacy of transvaginal tru-cut biopsy in a large group of patients with tumors in the small pelvis.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05610501
Lead Sponsor Universitaire Ziekenhuizen KU Leuven
Collaborators: UZ Leuven, Leuven, Belgium, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Charles University, Czech Republic, Karolinska Institutet and Department of Obstetrics and Gynecology, Södersjukhuset, Stockholm, Sweden.
Conditions Pelvic Cancer, Ovarian Cancer, Cervical Cancer, Uterus Cancer, Endometrial Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Sarcoma Uterus +1 more
Enrollment 200 participants
Start Date 2021-05-01
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-03